Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Regina Paleski

Set Alert for Articles By Regina Paleski

Latest From Regina Paleski

Executives On The Move: Eisai Taps Celgene And Sanofi VPs For Its Team, And Freeline Selects A CEO

Japanese big pharma Eisai taps Celgene and Sanofi execs as its new VPs for corporate affairs and market access. And Freeline Therapeutics, developer of gene therapies for bleeding disorders, selects a former Alnylam Pharma SVP as CEO.

Appointments BioPharmaceutical

Execs On The Move, February 2020

An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.

Appointments Companies

Executives On The Move: Exits From Takeda Vaccines And Novartis Institutes To CMO Positions And Board Changes At Merck & Co.

Takeda Vaccines VP switches to cancer immunotherapy and vaccine company Bavarian Nordic and Novartis Institutes exec moves to molecular medicines firm Boston Pharmaceuticals, each in the CMO position. Meanwhile, Merck & Co will add a scientific and a strategic expert to its board.

 

Appointments BioPharmaceutical

Executives On The Move: Bayer Names Upcoming Information Chief And Legal Hires At Eli Lilly And CytoDyn

Stryker tech officer will become Bayer AG’s chief information technology and digital transformation Officer in June. In addition, monoclonal antibody therapy firm CytoDyn and global pharma Eli Lilly each hire a general counsel.

Appointments BioPharmaceutical

Executives On The Move: Gamida Cell Decides On Regulatory Appointment, Twist Bio Announces A Promotion And A VP Leaves Sanofi Genzyme For Krystal Biotech

Cellular and immune therapeutics company Gamida Cell has a new chief regulatory and quality officer and the SVP, R&D at Twist Biosciences steps higher to the chief operating officer position. At Sanofi Genzyme a genetic diseases VP leaves to become chief commercial officer at Krystal Biotech.

Appointments BioPharmaceutical

Executives On The Move: New Picks For Finance Posts At Cambrex And Editas Medicine

Gene-editing company Editas Medicine appoints a new CFO, while Affimed and NexImmune bring new chief medical officers on board.

Appointments BioPharmaceutical
See All
UsernamePublicRestriction

Register